SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Mymetics Corporation (MYMX) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 5/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — MYMX
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.02
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-40.00
Book Value / Share$0.00
Revenue / Share$0.02
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2013 |
$0.02 |
$4.38M |
$6M |
137% |
| 2014 |
$-0.01 |
$2.4M |
$-3.26M |
-135.7% |
| 2015 |
$-0.01 |
$3.15M |
$-3.01M |
-95.4% |
| 2016 |
$-0.02 |
$1.25M |
$-5.96M |
-476% |
| 2017 |
$-0.01 |
$202K |
$-4.11M |
-2035.6% |
| 2018 |
$-0.01 |
$75K |
$-4.17M |
-5562.7% |
| 2019 |
$-0.01 |
$111K |
$-4.19M |
-3772.1% |
| 2020 |
$-0.01 |
$35K |
$-4.16M |
-11880% |
| 2021 |
$-0.02 |
$3K |
$-4.73M |
-157666.7% |
| 2022 |
$-40.00 |
$3K |
$-4.81M |
-160166.7% |
